Whalegun
Home

Acadia Pharmaceuticals ACAD spent $390K on lobbying in Q1 2023 · Health Issues, Medicare

Trade details

Type
Lobbying report
Amount
$390,000
Quarter
Q1 2023
Stock
Acadia Pharmaceuticals ACAD
Client
Acadia Pharmaceuticals
Reported
23/04/19

Up 5.4% from last quarter

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/03/01~23/04/30

Acadia Pharmaceuticals's other lobbying reports

Acadia Pharmaceuticals ACAD spent $390K on lobbying in Q1 2023 · Health Issues, Medicare | Whalegun